CN106581738A - Superabsorbent medical composite haemostasis sponge and preparation method thereof - Google Patents

Superabsorbent medical composite haemostasis sponge and preparation method thereof Download PDF

Info

Publication number
CN106581738A
CN106581738A CN201611127063.9A CN201611127063A CN106581738A CN 106581738 A CN106581738 A CN 106581738A CN 201611127063 A CN201611127063 A CN 201611127063A CN 106581738 A CN106581738 A CN 106581738A
Authority
CN
China
Prior art keywords
parts
alginate
linking agent
haemostasis
sponge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201611127063.9A
Other languages
Chinese (zh)
Inventor
潘明华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Nabeitong Environmental Technology Co Ltd
Original Assignee
Suzhou Nabeitong Environmental Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Nabeitong Environmental Technology Co Ltd filed Critical Suzhou Nabeitong Environmental Technology Co Ltd
Priority to CN201611127063.9A priority Critical patent/CN106581738A/en
Publication of CN106581738A publication Critical patent/CN106581738A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0005Ingredients of undetermined constitution or reaction products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0015Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0036Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057Ingredients of undetermined constitution or reaction products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0085Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention discloses a superabsorbent medical composite haemostasis sponge and a preparation method thereof. The haemostasis sponge comprises the raw materials: alginate, fibrin glue, sephadex gel, polyuronide hemicelluloses, hyaluronan, gluconic acid strontium, iron-dextrin, epigallocatechin, 5-methoxy-N,N-diisopropyltryptamine, mint alkyl diamine, eucalyptole, puffball powder, a cross-linking agent, tween-60, ethanol 2, and distilled water. The liquid absorbing capability of the medical composite haemostasis sponge is strong, haemostasis time is short, effect is good, invasion of an extraneous substance can be isolated, wound healing is promoted, and the superabsorbent medical composite haemostasis sponge can be widely used for haemostasis and restoration of burn, wound, and surgical operation wound, and has good application value.

Description

A kind of super absorbent medical compound hemostatic sponge and preparation method thereof
Technical field
The invention belongs to medical material tech field, and in particular to a kind of super absorbent medical compound hemostatic sponge and its preparation Method.
Background technology
Hemostasis is a complicated process, in addition to blood itself solidifies, pressure and other antihemorrhagic factors that outside gives Bleeding stopping period can also be shortened, promote wound healing.Good hemostatic material in medical use not only need to have common bleeding stopping period it is short, Haemostatic effect is good, can not increase the characteristics such as the infection of wound, and should not produce secondary insult, should also to material implanted With good biocompatibility, no antigen, degradable, and good with the adhesiveness of tissue are coincide with wound, wound surface place site Property the characteristic such as good, while also with repairing, the multi-functional such as treatment.Existing common hemostatic material mainly has:Sthptic sponge, only The products such as blood gauze, hemostasis gel, stanch fibre, tourniquet bandage, hemostatic micropowder, chitosan film and Fibrin Glue.Wherein, only Sea of blood silk floss common are collagen protein sponge, gelfoam and chitosan sponge etc., and which has extraordinary water absorption and swollen Swollen property, sponge can be expanded rapidly and oppress and block petechia after absorbing the moisture in blood, while can accelerate hematoblastic solidifying It is poly-, promote blood coagulation;The pore passage structure of sponge is also beneficial to oxygen and carbon dioxide passes through, and is that wound healing creates good ring Border.But the haemostatic effect and mechanical strength of the reality of existing sthptic sponge need further to improve.
The content of the invention
For this purpose, the present invention provides a kind of super absorbent medical compound hemostatic sponge and preparation method thereof, solve in prior art The haemostatic effect and mechanical strength of the reality of existing sthptic sponge need the deficiency for further improving.
For this purpose, the present invention provides super absorbent medical compound hemostatic sponge, in parts by weight, it is prepared from the following materials: Alginate 19-30 parts, Fibrin Glue 10-21 parts, sephadex 5-12 parts, poly alduronic acid hemicellulose 3-9 Part, hyaluronan 4-8 parts, gluconic acid strontium 1-4 parts, iron dextran 0.5-2 parts, epigallo catechin 1.2-3.6 parts, 5- Methoxyl group-N, N- diisopropyl tryptamines 0.8-2.4 parts, terpane diamidogen 0.6-1.8 parts, eucalyptol 0.4-1.3 parts, Lasiosphaera Seu Calvatia powder 0.8-2 parts, cross-linking agent 0.5-2.6 parts, Tween-60 1.5-3 parts, ethanol 25-38 parts, distilled water 60-80 parts.
An embodiment of the invention, wherein, the cross-linking agent is citric acid, sodium diacetate, iron chloride, poly- second The mixture of enol and sodium trimetaphosphate.
An embodiment of the invention, wherein, it is 1 that the cross-linking agent is weight ratio:0.5:1.2:0.9:2.7 The mixture of citric acid, sodium diacetate, iron chloride, polyvinyl alcohol and sodium trimetaphosphate.
An embodiment of the invention, wherein, the alginate is sodium alginate, ammonium alginate, alginic acid Potassium or alginic acid magnesium.
An embodiment of the invention, wherein, in parts by weight, it is prepared from the following materials:Alginate 21-28 parts, Fibrin Glue 11-20 parts, sephadex 5.7-9 parts, poly alduronic acid hemicellulose 3.4-8.6 parts, Hyaluronan 4.5-7 parts, gluconic acid strontium 1.6-3.5 parts, iron dextran 0.7-1.6 parts, epigallo catechin 1.4-3.3 Part, 5- methoxyl group-N, N- diisopropyl tryptamines 0.9-2.1 parts, terpane diamidogen 0.8-1.4 parts, eucalyptol 0.6-1.1 parts, horse Vigorous powder 1.1-1.8 parts, cross-linking agent 0.7-2.4 parts, Tween-60 1.7-2.6 parts, ethanol 28-35 parts, distilled water 64-78 parts.
For this purpose, the present invention provides the preparation method of super absorbent medical compound hemostatic sponge, the preparation method includes following Step:
(1)By weight, weigh raw material:Alginate 19-28 parts, Fibrin Glue 10-21 parts, sephadex 5-12 Part, poly alduronic acid hemicellulose 3-9 parts, hyaluronan 4-8 parts, gluconic acid strontium 1-4 parts, iron dextran 0.5-2 parts, table Nutgall catechin 1.2-3.6 parts, 5- methoxyl group-N, N- diisopropyl tryptamines 0.8-2.4 parts, terpane diamidogen 0.6-1.8 parts, Eucalyptol 0.4-1.3 parts, Lasiosphaera Seu Calvatia powder 0.8-2 parts, cross-linking agent 0.5-2.6 parts, Tween-60 1.5-3 parts, ethanol 25-38 parts, steaming Distilled water 60-80 part;
(2)Alginate and Fibrin Glue are added in distilled water, mix homogeneously, regulation pH value of solution are 8-10, are then heated Stirring 20-60 minutes, Lasiosphaera Seu Calvatia powder, iron dextran and gluconic acid strontium are added afterwards, continues stirring 20-60 minutes;
(3)Sephadex, poly alduronic acid hemicellulose and hyaluronan are added in ethanol, 40-60 DEG C is heated to, Room temperature is down to after stirring 4-8 hours, Tween-60, epigallo catechin, eucalyptol, 5- methoxyl group-N, N- bis- is sequentially added Isopropyl tryptamines and terpane diamidogen, stir 30-60 minutes;
(4)By step(3)Obtained mixed liquor adds step(2)In, stir, be subsequently adding cross-linking agent, with 50-100rpm Speed stirring 50-80 minutes;
(5)By step(4)Obtained mixed liquor is poured in mould, is then soaked in 5 hours in 2wt.% Klorvess Liquids, is taken out And lyophilization, and scrubbed drying, sterilizing, obtain final product.
Beneficial effects of the present invention are:
The imbibition ability of medical compound hemostatic sponge prepared by the present invention is strong, liquid absorbency rate up to 29 and its more than, bleeding stopping period It is short and effect is good, can in the 30s only venous hemorrhage, stop arterial hemorrhage in 200s, and its tensile strength reach 218.6- 225.6KPa, can completely cut off the invasion of external substance, and wound healing can be widely applied to burn, wound, surgical operation wound The hemostasis and reparation of mouth, with good using value.
Specific embodiment
With reference to embodiment, the present invention is described in further detail.Following examples are used to illustrate the present invention, but not For limiting the scope of the present invention.
Embodiment 1
A kind of preparation method of super absorbent medical compound hemostatic sponge, the preparation method are comprised the following steps:
(1)By weight, weigh raw material:19 parts of alginate, 10 parts of Fibrin Glue, 5 parts of sephadex, polysaccharide 3 parts of aldehydic acid hemicellulose, 4 parts of hyaluronan, 1 part of gluconic acid strontium, 0.5 part of iron dextran, epigallo catechin 1.2 Part, 5- methoxyl group-N, 0.8 part of N- diisopropyls tryptamines, 0.6 part of terpane diamidogen, 0.4 part of eucalyptol, 0.8 part of Lasiosphaera Seu Calvatia powder, friendship 0.5 part of agent of connection, 1.5 parts of Tween-60,25 parts of ethanol, 60 parts of distilled water;It is 1 that the cross-linking agent is weight ratio:1.3:1.2: 1.5:The mixture of 3 citric acid, sodium diacetate, iron chloride, polyvinyl alcohol and sodium trimetaphosphate;The alginate is Sargassum Sour sodium;
(2)Alginate and Fibrin Glue are added in distilled water, mix homogeneously, it is 8 to adjust pH value of solution, then heated and stirred 20 minutes, Lasiosphaera Seu Calvatia powder, iron dextran and gluconic acid strontium are added afterwards, continues stirring 20 minutes;
(3)Sephadex, poly alduronic acid hemicellulose and hyaluronan are added in ethanol, 40 DEG C is heated to, is stirred Room temperature is down to after mixing 4 hours, Tween-60, epigallo catechin, eucalyptol, 5- methoxyl group-N, N- diisopropyls is sequentially added Primary colours amine and terpane diamidogen, stir 30 minutes;
(4)By step(3)Obtained mixed liquor adds step(2)In, stir, be subsequently adding cross-linking agent, with the speed of 50rpm Degree stirring 50 minutes;
(5)By step(4)Obtained mixed liquor is poured in mould, is then soaked in 5 hours in 2wt.% Klorvess Liquids, is taken out And lyophilization, and scrubbed drying, sterilizing, obtain final product.
Embodiment 2
A kind of preparation method of super absorbent medical compound hemostatic sponge, the preparation method are comprised the following steps:
(1)By weight, weigh raw material:28 parts of alginate, 21 parts of Fibrin Glue, 12 parts of sephadex, poly 9 parts of alduronic acid hemicellulose, 8 parts of hyaluronan, 4 parts of gluconic acid strontium, 2 parts of iron dextran, epigallo catechin 3.6 Part, 5- methoxyl group-N, 2.4 parts of N- diisopropyls tryptamines, 1.8 parts of terpane diamidogen, 1.3 parts of eucalyptol, 2 parts of Lasiosphaera Seu Calvatia powder, crosslinking 2.6 parts of agent, 3 parts of Tween-60,38 parts of ethanol, 80 parts of distilled water;It is 1 that the cross-linking agent is weight ratio:0.5:1.2:0.9:2.7 Citric acid, sodium diacetate, iron chloride, the mixture of polyvinyl alcohol and sodium trimetaphosphate;The alginate is ammonium alginate;
(2)Alginate and Fibrin Glue are added in distilled water, mix homogeneously, it is 10 to adjust pH value of solution, and then heating is stirred Mix 60 minutes, add Lasiosphaera Seu Calvatia powder, iron dextran and gluconic acid strontium afterwards, continue stirring 60 minutes;
(3)Sephadex, poly alduronic acid hemicellulose and hyaluronan are added in ethanol, 60 DEG C is heated to, is stirred Room temperature is down to after mixing 8 hours, Tween-60, epigallo catechin, eucalyptol, 5- methoxyl group-N, N- diisopropyls is sequentially added Primary colours amine and terpane diamidogen, stir 60 minutes;
(4)By step(3)Obtained mixed liquor adds step(2)In, stir, be subsequently adding cross-linking agent, with 100rpm's Speed is stirred 80 minutes;
(5)By step(4)Obtained mixed liquor is poured in mould, is then soaked in 5 hours in 2wt.% Klorvess Liquids, is taken out And lyophilization, and scrubbed drying, sterilizing, obtain final product.
Embodiment 3
A kind of preparation method of super absorbent medical compound hemostatic sponge, the preparation method are comprised the following steps:
(1)By weight, weigh raw material:21 parts of alginate, 11 parts of Fibrin Glue, 5.7 parts of sephadex, poly 3.4 parts of alduronic acid hemicellulose, 4.5 parts of hyaluronan, 1.6 parts of gluconic acid strontium, 0.7 part of iron dextran, epigallocatechin gallate 1.4 parts of theine, 5- methoxyl group-N, 0.9 part of N- diisopropyls tryptamines, 0.8 part of terpane diamidogen, 0.6 part of eucalyptol, Lasiosphaera Seu Calvatia powder 1.1 parts, 0.7 part of cross-linking agent, 1.7 parts of Tween-60,28 parts of ethanol, 64 parts of distilled water;It is 1 that the cross-linking agent is weight ratio: 0.8:1.5:1.8:The mixture of 3.2 citric acid, sodium diacetate, iron chloride, polyvinyl alcohol and sodium trimetaphosphate;The Sargassum Hydrochlorate is potassium alginate;
(2)Alginate and Fibrin Glue are added in distilled water, mix homogeneously, it is 9 to adjust pH value of solution, then heated and stirred 40 minutes, Lasiosphaera Seu Calvatia powder, iron dextran and gluconic acid strontium are added afterwards, continues stirring 50 minutes;
(3)Sephadex, poly alduronic acid hemicellulose and hyaluronan are added in ethanol, 50 DEG C is heated to, is stirred Room temperature is down to after mixing 6 hours, Tween-60, epigallo catechin, eucalyptol, 5- methoxyl group-N, N- diisopropyls is sequentially added Primary colours amine and terpane diamidogen, stir 45 minutes;
(4)By step(3)Obtained mixed liquor adds step(2)In, stir, be subsequently adding cross-linking agent, with the speed of 80rpm Degree stirring 60 minutes;
(5)By step(4)Obtained mixed liquor is poured in mould, is then soaked in 5 hours in 2wt.% Klorvess Liquids, is taken out And lyophilization, and scrubbed drying, sterilizing, obtain final product.
Embodiment 4
A kind of preparation method of super absorbent medical compound hemostatic sponge, the preparation method are comprised the following steps:
(1)By weight, weigh raw material:28 parts of alginate, 20 parts of Fibrin Glue, 9 parts of sephadex, polysaccharide 8.6 parts of aldehydic acid hemicellulose, 7 parts of hyaluronan, 3.5 parts of gluconic acid strontium, 1.6 parts of iron dextran, epigallo catechin 3.3 parts, 5- methoxyl group-N, 2.1 parts of N- diisopropyls tryptamines, 1.4 parts of terpane diamidogen, 1.1 parts of eucalyptol, 1.8 parts of Lasiosphaera Seu Calvatia powder, 2.4 parts of cross-linking agent, 2.6 parts of Tween-60,35 parts of ethanol, 78 parts of distilled water;It is 1 that the cross-linking agent is weight ratio:0.8:1.5: 1.8:The mixture of 3.2 citric acid, sodium diacetate, iron chloride, polyvinyl alcohol and sodium trimetaphosphate;The alginate is sea Alginic acid magnesium;
(2)Alginate and Fibrin Glue are added in distilled water, mix homogeneously, it is 9.5 to adjust pH value of solution, and then heating is stirred Mix 30 minutes, add Lasiosphaera Seu Calvatia powder, iron dextran and gluconic acid strontium afterwards, continue stirring 45 minutes;
(3)Sephadex, poly alduronic acid hemicellulose and hyaluronan are added in ethanol, 60 DEG C is heated to, is stirred Room temperature is down to after mixing 8 hours, Tween-60, epigallo catechin, eucalyptol, 5- methoxyl group-N, N- diisopropyls is sequentially added Primary colours amine and terpane diamidogen, stir 50 minutes;
(4)By step(3)Obtained mixed liquor adds step(2)In, stir, be subsequently adding cross-linking agent, with the speed of 90rpm Degree stirring 70 minutes;
(5)By step(4)Obtained mixed liquor is poured in mould, is then soaked in 5 hours in 2wt.% Klorvess Liquids, is taken out And lyophilization, and scrubbed drying, sterilizing, obtain final product.
Comparative example 1
In place of this comparative example and the difference of embodiment 1 it is:Without gluconic acid strontium, 5- methoxyl group-N, N- diisopropyl tryptamines With poly alduronic acid hemicellulose.
Comparative example 2
In place of this comparative example and the difference of embodiment 1 it is:Without Lasiosphaera Seu Calvatia powder, iron dextran and eucalyptol.
Comparative example 3
In place of this comparative example and the difference of embodiment 1 it is:The cross-linking agent is sodium diacetate.
Properties of product are tested
Above-mentioned sponge products are cut into into the sample size of 1 × 1cm, and the testing standard according to this area carries out following performance survey Try, its test result is:
Bleeding stopping period/s(Venous hemorrhage) Bleeding stopping period/s(Arterial hemorrhage) Liquid absorbency rate Tensile strength/KPa
Embodiment 1 25±5 180±20 29 218.6
Embodiment 2 23±5 175±20 31 216.3
Embodiment 3 22±5 171±20 32 223.8
Embodiment 4 20±3 166±20 34 225.6
Comparative example 1 40±10 210±20 27 217.3
Comparative example 2 38±5 220±20 26 215.3
Comparative example 3 35±5 195±20 22 217.2
The imbibition ability of medical compound hemostatic sponge prepared by the present invention is strong, liquid absorbency rate up to 29 and its more than, bleeding stopping period It is short and effect is good, can in the 30s only venous hemorrhage, stop arterial hemorrhage in 200s, and its tensile strength reach 218.6- 225.6KPa, can completely cut off the invasion of external substance, and wound healing can be widely applied to burn, wound, surgical operation wound The hemostasis and reparation of mouth, with good using value.

Claims (6)

1. absorbent medical compound hemostatic sponge is surpassed, it is characterised in that in parts by weight, be prepared from the following materials:Alginic acid It is salt 19-30 parts, Fibrin Glue 10-21 parts, sephadex 5-12 parts, poly alduronic acid hemicellulose 3-9 parts, transparent Matter alkane 4-8 parts, gluconic acid strontium 1-4 parts, iron dextran 0.5-2 parts, epigallo catechin 1.2-3.6 parts, 5- methoxyl groups- N, N- diisopropyl tryptamines 0.8-2.4 parts, terpane diamidogen 0.6-1.8 parts, eucalyptol 0.4-1.3 parts, Lasiosphaera Seu Calvatia powder 0.8-2 parts, Cross-linking agent 0.5-2.6 parts, Tween-60 1.5-3 parts, ethanol 25-38 parts, distilled water 60-80 parts.
2. super absorbent medical compound hemostatic sponge according to claim 1, it is characterised in that the cross-linking agent is Fructus Citri Limoniae The mixture of acid, sodium diacetate, iron chloride, polyvinyl alcohol and sodium trimetaphosphate.
3. super absorbent medical compound hemostatic sponge according to claim 1, it is characterised in that the cross-linking agent is weight ratio For 1:0.5:1.2:0.9:The mixture of 2.7 citric acid, sodium diacetate, iron chloride, polyvinyl alcohol and sodium trimetaphosphate.
4. super absorbent medical compound hemostatic sponge according to claim 1, it is characterised in that the alginate is Sargassum Sour sodium, ammonium alginate, potassium alginate or alginic acid magnesium.
5. super absorbent medical compound hemostatic sponge according to claim 1, it is characterised in that in parts by weight, by following Raw material is prepared from:Alginate 21-28 parts, Fibrin Glue 11-20 parts, sephadex 5.7-9 parts, poly alditol Sour hemicellulose 3.4-8.6 parts, hyaluronan 4.5-7 parts, gluconic acid strontium 1.6-3.5 parts, iron dextran 0.7-1.6 parts, Epigallo catechin 1.4-3.3 parts, 5- methoxyl group-N, N- diisopropyl tryptamines 0.9-2.1 parts, terpane diamidogen 0.8-1.4 Part, eucalyptol 0.6-1.1 parts, Lasiosphaera Seu Calvatia powder 1.1-1.8 parts, cross-linking agent 0.7-2.4 parts, Tween-60 1.7-2.6 parts, ethanol 28- 35 parts, distilled water 64-78 parts.
6. the preparation method of absorbent medical compound hemostatic sponge is surpassed, it is characterised in that the preparation method is comprised the following steps:
(1)By weight, weigh raw material:Alginate 19-28 parts, Fibrin Glue 10-21 parts, sephadex 5-12 Part, poly alduronic acid hemicellulose 3-9 parts, hyaluronan 4-8 parts, gluconic acid strontium 1-4 parts, iron dextran 0.5-2 parts, table Nutgall catechin 1.2-3.6 parts, 5- methoxyl group-N, N- diisopropyl tryptamines 0.8-2.4 parts, terpane diamidogen 0.6-1.8 parts, Eucalyptol 0.4-1.3 parts, Lasiosphaera Seu Calvatia powder 0.8-2 parts, cross-linking agent 0.5-2.6 parts, Tween-60 1.5-3 parts, ethanol 25-38 parts, steaming Distilled water 60-80 part;
(2)Alginate and Fibrin Glue are added in distilled water, mix homogeneously, regulation pH value of solution are 8-10, are then heated Stirring 20-60 minutes, Lasiosphaera Seu Calvatia powder, iron dextran and gluconic acid strontium are added afterwards, continues stirring 20-60 minutes;
(3)Sephadex, poly alduronic acid hemicellulose and hyaluronan are added in ethanol, 40-60 DEG C is heated to, Room temperature is down to after stirring 4-8 hours, Tween-60, epigallo catechin, eucalyptol, 5- methoxyl group-N, N- bis- is sequentially added Isopropyl tryptamines and terpane diamidogen, stir 30-60 minutes;
(4)By step(3)Obtained mixed liquor adds step(2)In, stir, be subsequently adding cross-linking agent, with 50-100rpm Speed stirring 50-80 minutes;
(5)By step(4)Obtained mixed liquor is poured in mould, is then soaked in 5 hours in 2wt.% Klorvess Liquids, is taken out And lyophilization, and scrubbed drying, sterilizing, obtain final product.
CN201611127063.9A 2016-12-09 2016-12-09 Superabsorbent medical composite haemostasis sponge and preparation method thereof Withdrawn CN106581738A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611127063.9A CN106581738A (en) 2016-12-09 2016-12-09 Superabsorbent medical composite haemostasis sponge and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611127063.9A CN106581738A (en) 2016-12-09 2016-12-09 Superabsorbent medical composite haemostasis sponge and preparation method thereof

Publications (1)

Publication Number Publication Date
CN106581738A true CN106581738A (en) 2017-04-26

Family

ID=58597876

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611127063.9A Withdrawn CN106581738A (en) 2016-12-09 2016-12-09 Superabsorbent medical composite haemostasis sponge and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106581738A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107308487A (en) * 2017-05-31 2017-11-03 太仓卡斯特姆新材料有限公司 A kind of medical compound hemostatic sponge of biodegradable high water absorption and preparation method thereof
CN111867641A (en) * 2017-11-28 2020-10-30 巴克斯特国际公司 Absorbent for treating wound

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107308487A (en) * 2017-05-31 2017-11-03 太仓卡斯特姆新材料有限公司 A kind of medical compound hemostatic sponge of biodegradable high water absorption and preparation method thereof
CN111867641A (en) * 2017-11-28 2020-10-30 巴克斯特国际公司 Absorbent for treating wound

Similar Documents

Publication Publication Date Title
CN108744023B (en) Silk fibroin medical biological adhesive and preparation method thereof
CN105194740B (en) A kind of post-operation adhesion preventing hydrogel and preparation method thereof
AU2006329660B2 (en) Hemostatic material
CN108014366A (en) A kind of marine organism material composite hydrogel dressing and preparation method thereof
CN101700409A (en) Material prepared from purely natural material and used for wounds
CN108853570B (en) Hemostatic sponge and preparation method thereof
Xiang et al. A novel hydrogel based on Bletilla striata polysaccharide for rapid hemostasis: Synthesis, characterization and evaluation
CN104888265B (en) The preparation method of temperature sensitive type collagen-based compound hemostatic gel
CN106620824A (en) Preparation method for efficient anti-bacterial composite hemostatic sponge
CN105056285B (en) It is a kind of can adhesion organization crack growth factor combine dressing and preparation method thereof
CN114344556A (en) Polyphenol-silk fibroin-polyethylene glycol medical tissue adhesive, preparation method and application
CN102580138A (en) Polysaccharide composite film for arresting bleeding and preparation method thereof
CN105797203A (en) Alginate fiber based collagen sponge dressing and preparation method thereof
CN106975098B (en) Composite polysaccharide hemostatic composition and preparation method and application thereof
CN106581738A (en) Superabsorbent medical composite haemostasis sponge and preparation method thereof
US11357883B1 (en) Method for preparing absorbable haemostatic composition for body and haemostatic composition prepared thereby
CN108245700A (en) A kind of hydroxypropyl methyl cellulose chitosan film dressing and preparation method thereof
CN104353106A (en) Composition of fast hemostatic sponge gel and preparation method of composition
US11484623B2 (en) Dry pad comprising thrombin and pectin
CN104307031A (en) Preparation method and usage of external use skin repair material
CN106822984A (en) A kind of biocompatibility is strong, preventing tissue is adhered, the degradable absorption antibacterial anti hemorrhagic composition of wound healing promoting and application thereof
CN106474524A (en) A kind of degradable starch sthptic sponge and preparation method thereof
CN106963977B (en) A kind of Breviscapinun/chitosan composite aquogel for suppressing cicatrization and preparation method thereof
CN101700244B (en) Novel wound paste constructed by water absorption pad of purely natural material
CN115926359A (en) Double-bond bletilla striata polysaccharide-carboxymethyl chitosan gel and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20170426